TRIPLET combined with microwave ablation: A novel treatment for advanced hepatocellular carcinoma

Fei-Yu Zhao; Guo-Wei Si; Nian-Song Qian

doi:10.4251/wjgo.v17.i1.98572

TRIPLET combined with microwave ablation: A novel treatment for advanced hepatocellular carcinoma

World J Gastrointest Oncol. 2025 Jan 15;17(1):98572. doi: 10.4251/wjgo.v17.i1.98572.

Authors

Fei-Yu Zhao¹, Guo-Wei Si², Nian-Song Qian³

Affiliations

¹ Department of Thoracic Oncology, Respiratory and Critical Care Medicine, The Eighth Medical Center of People's Liberation Army General Hospital, Beijing 100853, China.
² Department of Gastroenterology, Fourth Medical Centre, General Hospital of the People's Liberation Army, Beijing 100142, China.
³ Senior Department of Thoracic Oncology, Respiratory and Critical Care Medicine, The Eighth Medical Center of People's Liberation Army General Hospital, Beijing 100091, China. [email protected].

Abstract

This editorial comments on a study by Zuo et al. The focus is on the efficacy of hepatic arterial infusion chemotherapy combined with camrelizumab and apatinib (the TRIPLET regimen), alongside microwave ablation therapy, in treating advanced hepatocellular carcinoma (HCC). The potential application of this combination therapy for patients with advanced HCC is evaluated.

Keywords: Apatinib; Camrelizumab; Hepatic arterial infusion chemotherapy; Hepatocellular carcinoma; Microwave ablation.

Publication types

Editorial